News

New York Post1mon
FDA approves Moderna's next-generation COVID vaccine for adults 65 or older - New York Post
The US Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above. Moderna expects to have the vaccine available for the 2025-2026 ...
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data
Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and ...
The American Journal of Managed Care1mon
FDA Approves Jivi for Pediatric Patients Aged 7 to 12 Years With Hemophilia A
Previously, Jivi was approved in September 2018 for adults and adolescents aged 12 years and older with this hemophilia subtype. 2 According to data collected from federally funded hemophilia ...
UPI1mon
FDA approves Novavax's COVID-19 vaccine with limitations
May 18 (UPI) --The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.The agency approved the vaccine only for people 65 and older ...
PBS1mon
FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use - PBS
WASHINGTON (AP) — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...
STAT20d
FDA approves Moderna RSV vaccine use for people aged 18 to 59 - STAT
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they ...
Nasdaq17d
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
Gilead Sciences, Inc.GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the prevention of HIV.. The regulatory body approved lenacapavir, under the ...
Detroit News1mon
FDA approves Novavax COVID-19 shot but with unusual restrictions - The Detroit News
Washington — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.. Novavax makes the nation’s only traditional ...
CNN1mon
FDA may limit future Covid-19 shots to older people and those at risk of serious infection - CNN
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious ...
Applied Clinical Trials Online10d
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...
NPR1mon
COVID boosters will be updated for next fall and winter - NPR
Moderna, Pfizer/BioNTech and Novavax should target strains related to the JN.1 variant with their vaccines for next fall and winter because that strain is closer to the new variants of the virus ...
Nature27d
FDA approves a c-MET-targeted ADC for lung cancer - Nature
The FDA has approved AbbVie’s telisotuzumab vedotin (Emrelis) for locally advanced or metastatic, non-squamous non-small-cell lung cancer (NSCLC) with high c-MET protein overexpression after ...